Jingjing Yan

No ORCID on file · 8 papers in corpus · active 2016-2026

Study types

  • article 5
  • other 1
  • peer-review 1
  • review 1

Condition tags

  • endometriosis 7
  • mesh:D004715 3
  • infertility 2
  • adenomyosis 2
other 2026
British journal of pharmacology ·doi:10.1111/bph.70360

BACKGROUND AND PURPOSE: Endometriosis is a chronic, hormone-dependent disorder characterized by ectopic implantation of endometrial tissue, often accompanied by pain and infertility. Although the progesterone receptor modulator RU486 is eff…

peer-review 2024
·doi:10.1039/d4tb01755b/v2/response1
review 2024
Journal of materials chemistry. B ·doi:10.1039/d4tb01755b

Endometriosis and adenomyosis are debilitating gynecological conditions that severely affect the quality of life of women. Traditional diagnostic and treatment methods, including laparoscopic surgery and hormonal therapy, face significant l…

article 2024
Drug delivery and translational research ·doi:10.1007/s13346-024-01661-3
article 2022
Ginekologia polska ·doi:10.5603/gp.a2022.0078

OBJECTIVES: Endometriosis is a common gynecological disease that seriously affects women's health and quality of life. However, the pathogenesis of endometriosis remains uncertain. This study aims to find the key microRNAs (miRNAs) and mRNA…

article 2018
·doi:10.1080/14647273.2018.1543898

This study investigated the association between inflammation in infertile women and the risk of IVF-ET failure, as well as the potential effects of various lifestyles on this association. A total of 84 women undergoing IVF-ET in Beijing Chi…

article 2016
·doi:10.3760/cma.j.issn.1008-6315.2016.12.017

Objective To investigation the influencing factors of pregnancy in patients with endometriosis after laparoscopic treatment. Methods One hundred and twenty cases of endometriosis type infertility underwent laparoscopic surgery patien…

article 2016
International journal of nanomedicine ·doi:10.2147/ijn.s99692

To identify a new drug candidate for treating endometriosis which has fewer side effects, a new polymeric nanoparticle gene delivery system consisting of polyethylenimine-grafted chitosan oligosaccharide (CSO-PEI) with hyaluronic acid (HA) …